Annual total expenses:
$800.53M+$167.50M(+26.46%)Summary
- As of today (September 17, 2025), PCRX annual total expenses is $800.53 million, with the most recent change of +$167.50 million (+26.46%) on December 31, 2024.
- During the last 3 years, PCRX annual total expenses has risen by +$300.97 million (+60.25%).
- PCRX annual total expenses is now at all-time high.
Performance
PCRX Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$171.97M+$11.22M(+6.98%)Summary
- As of today (September 17, 2025), PCRX quarterly total expenses is $171.97 million, with the most recent change of +$11.22 million (+6.98%) on June 30, 2025.
- Over the past year, PCRX quarterly total expenses has increased by +$24.92 million (+16.95%).
- PCRX quarterly total expenses is now at all-time high.
Performance
PCRX Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
PCRX Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.5% | +16.9% |
| 3 y3 years | +60.3% | +10.1% |
| 5 y5 years | +85.3% | +111.7% |
PCRX Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +60.3% | at high | +20.4% |
| 5 y | 5-year | at high | +181.8% | at high | +111.7% |
| alltime | all time | at high | +1819.2% | at high | +1996.9% |
PCRX Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $171.97M(+7.0%) |
| Mar 2025 | - | $160.75M(+1.9%) |
| Dec 2024 | $800.53M(+26.5%) | $157.72M(+7.6%) |
| Sep 2024 | - | $146.62M(-0.3%) |
| Jun 2024 | - | $147.05M(-3.3%) |
| Mar 2024 | - | $152.00M(+3.2%) |
| Dec 2023 | $633.02M(-2.7%) | $147.28M(+3.1%) |
| Sep 2023 | - | $142.85M(-2.3%) |
| Jun 2023 | - | $146.20M(-3.4%) |
| Mar 2023 | - | $151.32M(-4.1%) |
| Dec 2022 | $650.91M(+30.3%) | $157.71M(+8.3%) |
| Sep 2022 | - | $145.69M(-6.8%) |
| Jun 2022 | - | $156.23M(+14.7%) |
| Mar 2022 | - | $136.26M(+19.2%) |
| Dec 2021 | $499.55M(+75.8%) | $114.33M(+19.0%) |
| Sep 2021 | - | $96.05M(-4.5%) |
| Jun 2021 | - | $100.60M(+3.0%) |
| Mar 2021 | - | $97.72M(-7.3%) |
| Dec 2020 | $284.12M(-34.2%) | $105.43M(+6.3%) |
| Sep 2020 | - | $99.17M(+22.1%) |
| Jun 2020 | - | $81.23M(-12.0%) |
| Mar 2020 | - | $92.30M(-14.3%) |
| Dec 2019 | $432.04M(+27.9%) | $107.75M(+13.8%) |
| Sep 2019 | - | $94.65M(+0.8%) |
| Jun 2019 | - | $93.92M(+5.5%) |
| Mar 2019 | - | $88.99M(+7.5%) |
| Dec 2018 | $337.75M(+2.6%) | $82.80M(+6.0%) |
| Sep 2018 | - | $78.14M(+1.0%) |
| Jun 2018 | - | $77.40M(-5.0%) |
| Mar 2018 | - | $81.45M(+15.5%) |
| Dec 2017 | $329.24M | $70.50M(-0.2%) |
| Sep 2017 | - | $70.65M(-14.1%) |
| Jun 2017 | - | $82.22M(-1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $83.33M(+10.6%) |
| Dec 2016 | $314.32M(+27.2%) | $75.36M(-15.5%) |
| Sep 2016 | - | $89.22M(+17.3%) |
| Jun 2016 | - | $76.08M(+12.3%) |
| Mar 2016 | - | $67.73M(-3.4%) |
| Dec 2015 | $247.14M(+16.9%) | $70.13M(+22.8%) |
| Sep 2015 | - | $57.10M(-0.4%) |
| Jun 2015 | - | $57.33M(+4.3%) |
| Mar 2015 | - | $54.98M(+2.0%) |
| Dec 2014 | $211.38M(+41.4%) | $53.87M(+1.6%) |
| Sep 2014 | - | $53.03M(+6.1%) |
| Jun 2014 | - | $50.01M(+8.9%) |
| Mar 2014 | - | $45.92M(+5.8%) |
| Dec 2013 | $149.46M(+63.6%) | $43.38M(+20.3%) |
| Sep 2013 | - | $36.07M(+23.7%) |
| Jun 2013 | - | $29.15M(-3.6%) |
| Mar 2013 | - | $30.23M(+15.0%) |
| Dec 2012 | $91.36M(+54.8%) | $26.28M(+8.6%) |
| Sep 2012 | - | $24.19M(+27.5%) |
| Jun 2012 | - | $18.97M(+0.2%) |
| Mar 2012 | - | $18.94M(+18.9%) |
| Dec 2011 | $59.02M(+41.5%) | $15.93M(+25.5%) |
| Sep 2011 | - | $12.69M(+4.3%) |
| Jun 2011 | - | $12.17M(+10.8%) |
| Mar 2011 | - | $10.98M(+33.9%) |
| Dec 2010 | $41.71M(-10.7%) | $8.20M(-25.3%) |
| Sep 2010 | - | $10.98M(+26.5%) |
| Jun 2010 | - | $8.68M(-7.6%) |
| Mar 2010 | - | $9.40M(-22.3%) |
| Dec 2009 | $46.71M(-16.3%) | $12.09M(+22.4%) |
| Sep 2009 | - | $9.88M |
| Dec 2008 | $55.79M(+25.3%) | - |
| Dec 2007 | $44.53M | - |
FAQ
- What is Pacira BioSciences, Inc. annual total expenses?
- What is the all time high annual total expenses for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. annual total expenses year-on-year change?
- What is Pacira BioSciences, Inc. quarterly total expenses?
- What is the all time high quarterly total expenses for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. quarterly total expenses year-on-year change?
What is Pacira BioSciences, Inc. annual total expenses?
The current annual total expenses of PCRX is $800.53M
What is the all time high annual total expenses for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high annual total expenses is $800.53M
What is Pacira BioSciences, Inc. annual total expenses year-on-year change?
Over the past year, PCRX annual total expenses has changed by +$167.50M (+26.46%)
What is Pacira BioSciences, Inc. quarterly total expenses?
The current quarterly total expenses of PCRX is $171.97M
What is the all time high quarterly total expenses for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high quarterly total expenses is $171.97M
What is Pacira BioSciences, Inc. quarterly total expenses year-on-year change?
Over the past year, PCRX quarterly total expenses has changed by +$24.92M (+16.95%)